Expertise in
10
conditions

Kazuhiro Kurasawa

Mibu, JP 
Expertise in
10
conditions
Mibu, JP 

Overview

Kazuhiro Kurasawa practices practicing medicine in Mibu, Japan.

Mr. Kurasawa is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Myositis, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Rheumatoid Lung Disease.

He is actively involved in clinical research, co-authoring 49 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Mibu, Japan
Other Locations
Tochigi, Japan
Japan
Saitama, Japan
Chiba, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
Enrollment Status: Terminated
Publish Date: April 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial
Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial
Enrollment Status: Unknown
Publish Date: January 27, 2021
Intervention Type: Drug
Study Drugs: Rituximab, Glucocorticoids
Study Phase: Phase 4
View 1 Less Clinical Trial

49 Total Publications

Autoantibodies against adenosine deaminase acting on RNA1 (ADAR1) in patients with systemic lupus erythematosus: its relationship to clinical features and other autoantibodies.
Autoantibodies against adenosine deaminase acting on RNA1 (ADAR1) in patients with systemic lupus erythematosus: its relationship to clinical features and other autoantibodies.
Journal: Modern rheumatology
Published: February 17, 2026

Frequently Asked Questions about Kazuhiro Kurasawa

Is Kazuhiro Kurasawa a top-rated expert for Myositis?

MediFind is an objective health platform that identifies experts based on real-world data. Kazuhiro Kurasawa is classified as an Advanced expert for Myositis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kazuhiro Kurasawa participate in research or clinical trials?

Yes. Kazuhiro Kurasawa has published 49 articles and abstracts on conditions like Myositis. You can view a list of Kazuhiro Kurasawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kurasawa's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 21 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile